VALBY, Denmark, May 8, 2025 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) will present key pipeline data and patient perspectives from the phase II AMULET trial, investigating amlenetug as a potential new treatment option targeting the rare neurological disorder, multiple system atrophy...
Hence then, the article about lundbeck to share pipeline data and key insights into the progression of rare disease multiple system atrophy at international msa congress in boston was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Lundbeck to share pipeline data and key insights into the progression of rare disease, Multiple System Atrophy, at International MSA Congress in Boston )
Also on site :
- Drew Barrymore’s ‘Fast-to-Boil’ Electric Kettle Is the Cozy Countertop Upgrade We’re Eyeing Ahead of Fall
- Transform Health Partners Announces Acquisition of Northwest Weight & Wellness Center and Sound Surgeons, Expanding Its High ‑ Quality Care Network
- Man, 26, held over death of British woman found in suitcase is Christian aid worker and champion boxer